SynthesisESMO open2022

Maintenance therapy with a poly(ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: individual patient data and trial-level meta-analysis.

S Gulia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.